T. W. Boesgaard, S. I. Castella, G. Andersen, A. Albrechtsen, T. Sparso, K. Borch-Johnsen, T. Jorgensen, T. Hansen and O. Pedersen
Diabetic Medicine, 2007, 24(7), 702-706. DOI: 10.1111/j.1464-5491.2007.02110.x
Aims The glutamate decarboxylase gene (GAD2) encodes GAD65, an enzyme catalysing the production of the γ-aminobutyric acid (GABA) which interacts with neuropeptide Y to stimulate food intake. It has been suggested that in pancreatic islets, GABA serves as a functional regulator of pancreatic hormone release. Conflicting results have been reported concerning the potential impact of GAD2 variation on estimates of energy metabolism. The aim of this study was to elucidate potential associations between the GAD2−243A→G polymorphism and levels of body mass index (BMI) and estimates of glycaemia.
Methods Using high-throughput chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, the GAD2−243A→G (rs2236418) polymorphism was genotyped in a population-based sample (Inter99) of 5857 middle-aged, unrelated Danish White subjects.
Results The G-allele was associated with modestly lower BMI (P = 0.01). In a case–control study of obesity, the G-allele frequency in 2582 participants with BMI < 25 kg/m
Conclusion The present study suggests that the GAD2−243A→G polymorphism in a population of middle-aged White people associates with a modest reduction in BMI and fasting and OGTT-related plasma glucose levels.
Diabetic Medicine, 2008, 25(1), 11-18. DOI: 10.1111/j.1464-5491.2007.02314.xThe association of genetic variants in Kruppel-like factor 11 and Type 2 diabetes in the Japanese population
Diabetic Medicine, 2008, 25(1), 19-26. DOI: 10.1111/j.1464-5491.2007.02315.xTwo susceptible diabetogenic variants near/in MTNR1B are associated with fasting plasma glucose in a Han Chinese cohort
Diabetic Medicine, 2010, 27(5), 598-602. DOI: 10.1111/j.1464-5491.2010.02975.xAssociation and evolutionary studies of the melatonin receptor 1B gene (MTNR1B) in the self-contained population of Sorbs from Germany
Diabetic Medicine, 2011, 28(11), 1373-1380. DOI: 10.1111/j.1464-5491.2011.03374.xType 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry
Diabetic Medicine, 2012, 29(6), 761-766. DOI: 10.1111/j.1464-5491.2011.03529.xTrends of diabetes according to body mass index levels in Iran: results of the national Surveys of Risk Factors of Non-Communicable Diseases (1999-2007)
Diabetic Medicine, 2010, 27(11), 1233-1240. DOI: 10.1111/j.1464-5491.2010.03103.xAssociation between childhood obesity and subsequent Type 1 diabetes: a systematic review and meta-analysis
Diabetic Medicine, 2011, 28(1), 10-18. DOI: 10.1111/j.1464-5491.2010.03160.xBody mass index and risk of all-cause and cardiovascular mortality in hospitalized elderly patients with diabetes mellitus
Diabetic Medicine, 2009, 26(3), 253-259. DOI: 10.1111/j.1464-5491.2009.02672.xPregravid body mass index as a predictor of gestational diabetes mellitus
Diabetic Medicine, 2009, 26(4), 334-338. DOI: 10.1111/j.1464-5491.2009.02695.xAn FTO variant is associated with Type 2 diabetes in South Asian populations after accounting for body mass index and waist circumference
Diabetic Medicine, 2011, 28(6), 673-680. DOI: 10.1111/j.1464-5491.2011.03257.xThe Pro12Ala polymorphism of the PPARG gene is not associated with the metabolic syndrome in an urban population of middle-aged Swedish individuals
Diabetic Medicine, 2008, 25(8), 902-908.Lack of association between polymorphisms in the gene encoding protein tyrosine phosphatase 1B (PTPN1) and risk of Type 2 diabetes
Diabetic Medicine, 2007, 24(6), 650-655. DOI: 10.1111/j.1464-5491.2007.02132.xThe majority of cases of neonatal diabetes in Spain can be explained by known genetic abnormalities
Diabetic Medicine, 2007, 24(7), 707-713. DOI: 10.1111/j.1464-5491.2007.02140.xThe associations of apolipoprotein E and angiotensin-converting enzyme polymorphisms and cognitive function in Type 1 diabetes based on an 18-year follow-up of the DCCT cohort
Diabetic Medicine, 2010, 27(1), 15-22. DOI: 10.1111/j.1464-5491.2009.02885.xAssociation of TCF7L2 gene variants with low GAD autoantibody titre in LADA subjects (NIRAD Study 5)
Diabetic Medicine, 2010, 27(6), 701-704. DOI: 10.1111/j.1464-5491.2010.02997.xPrevalence and clinical characteristics of maternally inherited diabetes and deafness caused by the mt3243A > G mutation in young adult diabetic subjects in Sri Lanka
Diabetic Medicine, 2008, 25(3), 370-374. DOI: 10.1111/j.1464-5491.2007.02377.xLack of pancreatic body and tail in HNF1B mutation carriers
Diabetic Medicine, 2008, 25(7), 782-787. DOI: 10.1111/j.1464-5491.2008.02460.xRD Lawrence Lecture 2009 Old genes, new tricks: learning about blood glucose regulation from naturally occurring genetic variation in humans
Diabetic Medicine, 2009, 26(11), 1083-1089. DOI: 10.1111/j.1464-5491.2009.02860.xAssociation of the POU class 2 homeobox 1 gene (POU2F1) with susceptibility to Type 2 diabetes in Chinese populations
Diabetic Medicine, 2010, 27(12), 1443-1449. DOI: 10.1111/j.1464-5491.2010.03124.xSequencing PDX1 (insulin promoter factor 1) in 1788 UK individuals found 5% had a low frequency coding variant, but these variants are not associated with Type 2 diabetes
Diabetic Medicine, 2011, 28(6), 681-684. DOI: 10.1111/j.1464-5491.2011.03269.xAssociation of a polymorphism of BTN2A1 with Type 2 diabetes mellitus in Japanese individuals
Diabetic Medicine, 2011, 28(11), 1381-1387. DOI: 10.1111/j.1464-5491.2011.03358.xMechanistic insights into insulin resistance in the genetic era
Diabetic Medicine, 2011, 28(12), 1476-1486. DOI: 10.1111/j.1464-5491.2011.03463.xGenetics, genomics and metabolomics: new insights into maternal metabolism during pregnancy
Diabetic Medicine, 2014, 31(3), 254-262. DOI: 10.1111/dme.12352Nateglinide combination therapy with basal insulin and metformin in patients with Type 2 diabetes
Diabetic Medicine, 2009, 26(4), 409-415. DOI: 10.1111/j.1464-5491.2009.02691.xDramatic improvement of glucose control after plasmapheresis and prednisone in a patient with Type 1 diabetes
Diabetic Medicine, 2009, 26(9), 951-952. DOI: 10.1111/j.1464-5491.2009.02776.xEthnic variation in the correlation between random serum glucose concentration and glycated haemoglobin
Diabetic Medicine, 2009, 26(2), 128-133. DOI: 10.1111/j.1464-5491.2008.02646.xDeterminants of blood glucose and insulin in healthy 9-month-old term Danish infants; the SKOT cohort
Diabetic Medicine, 2010, 27(12), 1350-1357. DOI: 10.1111/j.1464-5491.2010.03134.xThe relationship between low vital capacity and impaired glucose metabolism in men
Diabetic Medicine, 2010, 27(12), 1460-1461. DOI: 10.1111/j.1464-5491.2010.03112.xDiabetes, impaired fasting glucose and their relations to plasma pro-inflammatory cytokines: a population-based study in China
Diabetic Medicine, 2010, 27(12), 1461-1463. DOI: 10.1111/j.1464-5491.2010.03122.xPrevalence of diabetes and impaired glucose regulation in Estonia
Diabetic Medicine, 2011, 28(4), 504-505. DOI: 10.1111/j.1464-5491.2010.03218.xAssociation and evolutionary studies of the melatonin receptor 1B gene (MTNR1B) in the self-contained population of Sorbs from Germany
Diabetic Medicine, 2011, 28(11), 1373-1380. DOI: 10.1111/j.1464-5491.2011.03374.xSelf-monitoring of blood glucose in Type 2 diabetes: cross-sectional analyses in 1993, 1999 and 2009
Diabetic Medicine, 2012, 29(6), 792-795. DOI: 10.1111/j.1464-5491.2011.03567.xAccess to insulin pump therapy and continuous glucose monitoring - is it an even playing field?
Diabetic Medicine, 2012, 29(8), 971-971. DOI: 10.1111/j.1464-5491.2012.03734.xManagement of raised glucose, a clinical decision tool to reduce length of stay of patients with hyperglycaemia
Diabetic Medicine, 2013, 30(1), 81-87. DOI: 10.1111/dme.12006Diet quality is prospectively associated with incident impaired fasting glucose in older adults
Diabetic Medicine, 2013, 30(5), 557-562. DOI: 10.1111/dme.12109Do high fasting glucose levels suggest nocturnal hypoglycaemia? The Somogyi effect-more fiction than fact?
Diabetic Medicine, 2013, 30(8), 914-917. DOI: 10.1111/dme.12175Impact of continuous glucose monitoring on diabetes management and marital relationships of adults with Type 1 diabetes and their spouses: a qualitative study
Diabetic Medicine, 2014, 31(1), 47-54. DOI: 10.1111/dme.12276Two-hour post-load plasma glucose levels are associated with carotid intima-media thickness in subjects with normal glucose tolerance
Diabetic Medicine, 2014, 31(1), 76-83. DOI: 10.1111/dme.12288Evidence for continuous glucose monitoring: sufficient for reimbursement?
Diabetic Medicine, 2014, 31(2), 122-125. DOI: 10.1111/dme.12341Elevated liver enzymes are related to progression to impaired glucose tolerance in Japanese men
Diabetic Medicine, 2014, 31(5), 552-558. DOI: 10.1111/dme.12345Post-partum weight loss and glucose metabolism in women with gestational diabetes: the DEBI Study
Diabetic Medicine, 2014, 31(7), 862-867. DOI: 10.1111/dme.12425Impact of rosiglitazone on body composition, hepatic fat, fatty acids, adipokines and glucose in persons with impaired fasting glucose or impaired glucose tolerance: a sub-study of the DREAM trial
Diabetic Medicine, 2014, 31(9), 1086-1092. DOI: 10.1111/dme.12512